Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

Share Price is delayed by 15 minutes
Get Live Data
25.75    0.00 (0.00%)
Bid:
25.50
Ask:
26.00
Spread: 0.50 (1.961%)
Market Cap: £129.66m
DUKE Live PriceLast checked at - London Stock Exchange

Intraday Duke Capital Share Chart

New Royalty Partner

16 Feb 2021 07:00

RNS Number : 1749P
Duke Royalty Limited
16 February 2021
 

 

16 February 2021

 

Duke Royalty Limited

 

("Duke Royalty", "Duke" or the "Company")

 

New Royalty Agreement with a Leading UK Steel Fabrication Business

 

Duke Royalty, a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, is pleased to announce that it has further diversified its revenue base by entering into a £6.2 million royalty financing agreement (the "Financing") with Meteor HoldCo Limited, which undertakes business as Fabrikat (Nottingham) Limited ("Fabrikat"). Formed in 1985 and based in Sutton-in-Ashfield, UK, Fabrikat is a fabricator of steel products supplying the UK street lighting and guardrail markets.

 

Highlights:

 

· Initial cash yield of approximately 14% per annum via monthly payments, which commence immediately

· 30-year secured financing, with distributions to be adjusted annually to reflect Fabrikat's consolidated revenue growth, on typical Duke terms

· Fabrikat has a long history of steady turnover and profitability, providing street lighting columns, guardrails and more bespoke products to local councils around the UK via contractors and Original Equipment Manufacturers ("OEMs")

· Duke's investment will facilitate a management buyout ("MBO") of two shareholders who, in recent years, have handed over the day to day running of the business to the current management team which has a combined tenure in the business of more than 60 years and lead all aspects of Fabrikat's operations

· As part of the recapitalisation, Duke will receive a 30% equity stake in the business

 

Neil Johnson, CEO of Duke Royalty, said:

 

"Fabrikat is a well-managed business with a longstanding track record of profitability, making it an ideal royalty partner for Duke. The business' long history of growing market share and its ability to withstand and successfully navigate challenging environments, including the recent turbulence created by the pandemic, makes us confident of the Company's short and long-term future prospects. Our support of this MBO reflects our confidence in the management team's ability to continue the success achieved to date and illustrates how effective our capital is in MBO situations.

 

"Additionally, with Duke's existing credit facility with Pollen Street Capital, we are well positioned to make more investments in the coming months as we focus on capitalising on the increasing demand for long term, flexible sources of finance."

 

Paul Allen, CFO of Fabrikat, said:

 

"Duke's investment solution has been a great fit for this transaction. By taking on Duke's capital, the other members of the MBO team and I can assume operational control and a majority equity shareholding in a company where we have worked for most of our careers. We are excited to take Fabrikat forward and build on the excellent reputation of the firm."

 

Further information regarding Fabrikat

Fabrikat was founded in 1985 and is now the largest independently owned manufacturer of lighting columns and guardrails in the UK. Fabrikat designs, manufactures and supplies street lighting columns, traffic management and telecommunication structures, pedestrian guardrail, parapet, fencing and street furniture products. Leveraging its decades of experience and expertise in manufacturing and engineering, it has broadened its offering to include column testing, evaluation and asset management services.

Fabrikat has a diverse and expanding customer base, supplying local authorities, contractors, developers, specifiers, wholesalers, and lighting OEMs. Increasingly it is pivoting into higher margin, bespoke sub-sectors.

Two members of the MBO Team have been at the company for more than 30 years and across the management team there is deep technical expertise in the steel fabrication market. The company is based in Sutton-in-Ashfield, UK and employs c.80 staff across its production and administrative functions.

About the Financing

 

Duke has committed £6.2 million of capital to enable the current management team to shape the future growth and build on the stable foundations of a long-standing, profitable business. Importantly, there will be no change to the day-to-day management of Fabrikat.

 

The terms of the Financing are in line with Duke's typical investment criteria. The Financing is provided through a combination of a secured loan and preference shares and Duke will be entitled to monthly distributions (the "Distribution") beginning in March 2021.

 

In line with Duke's other investments, and reflective of the participating nature of Duke's business model, the Distribution will be adjusted annually based on the percentage change in total combined gross revenues of the Group for the 12 months to 31 December 2021, compared to the prior financial (calendar) year. The first adjustment will occur from March 2022. The annual adjustment in the Distribution will be subject to an agreed collar.

 

The Financing is for a period of 30 years, with the Distribution payable to Duke throughout the duration of this term, unless Fabrikat utilises an early buyback option which will trigger an early redemption payment to Duke. In addition, Duke has received 30% of the fully diluted ordinary equity of the Group as part of its investment.

Duke Royalty Portfolio

A full list of Duke's current Royalty Partners are now included for reference on our Partners page of our website: www.dukeroyalty.com/partners

 

 

***ENDS***

 

For further information, please visit www.dukeroyalty.com or contact:

 

Duke Royalty Limited

Neil Johnson / Charlie Cannon Brookes / Hugo Evans

 

 

+44 (0) 1481 741 240

Cenkos Securities plc 

(Nominated Adviser

and Joint Broker)

 

Stephen Keys / Callum Davidson / Julian Morse / Michael Johnson

 

+44 (0) 207 397 8900

 

Canaccord Genuity

(Joint Broker)

 

Adam James / Georgina McCooke

+44 (0) 207 523 8000

SEC Newgate (PR)

Elisabeth Cowell/ Tom Carnegie/ Megan Kovach

+ +44 (0) 20 3757 6880 dukeroyalty@secnewgate.co.uk

 

About Duke Royalty

 

Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon publication of this announcement, this inside information is now considered to be in the public domain.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGREAXASFSKFEFA
Date   Source Headline
28th May 20267:00 amRNSNotice of Results & Investor Presentation
31st Mar 20267:00 amRNSTrading and Operational Update
19th Mar 20267:00 amRNSInterim Dividend and Dividend Declaration
26th Jan 20267:00 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSFollow-On Investment into Tristone Healthcare Ltd
22nd Dec 20257:00 amRNSFollow-On Investment into Tristone Healthcare Ltd
18th Dec 20257:00 amRNSInterim Dividend and Dividend Declaration
4th Dec 20257:00 amRNSInterim Financial Results
17th Oct 20257:00 amRNSFollow-On Investment into Step Investments Limited
1st Oct 20257:00 amRNSFollow-On Investment into Integrum Group Holdings
29th Sep 20257:00 amRNSTrading Update
18th Sep 20257:00 amRNSInterim Dividend and Dividend Declaration
4th Aug 202511:17 amRNSResult of Annual General Meeting
1st Aug 20258:08 amRNSDirector/PDMR Dealings
11th Jul 20257:00 amRNSAnnual Report & Notice of Annual General Meeting
25th Jun 20257:00 amRNSFinal Results for the year ended 31 March 2025
19th Jun 20257:00 amRNSInterim Dividend and Dividend Declaration
2nd Jun 20257:00 amRNSFollow-On Investment into Existing Capital Partner
27th May 20257:00 amRNSNotice of Results & Investor Presentation
2nd Apr 20257:00 amRNSFollow-On Investment into Existing Capital Partner
31st Mar 20257:00 amRNSTrading and Operational Update
20th Mar 20257:00 amRNSInterim Dividend and Dividend Declaration
19th Feb 20257:00 amRNSFollow-On Investment into BPVA (Ireland) Limited
30th Dec 20247:00 amRNSTrading and Operational Update
17th Dec 202412:50 pmRNSInterim Dividend and Dividend Declaration
16th Dec 20247:00 amRNSInterim Results for the six months ended 30 Sep 24
4th Dec 20249:40 amRNSDirector/PDMR Shareholding
3rd Dec 202411:34 amRNSResult of General Meeting and Issue of Equity
22nd Nov 20243:38 pmRNSResult of Retail Offer and Broker Option
15th Nov 20247:00 amRNSResult of Placing
14th Nov 20245:02 pmRNSRetail Offer to raise up to £3.0 million
14th Nov 20245:01 pmRNSIssue of Equity
30th Sep 20247:00 amRNSTrading and Operational Update
19th Sep 20247:00 amRNSInterim Dividend and Dividend Declaration
3rd Sep 20247:00 amRNSFollow-On Investment into United Glass Group
1st Aug 20243:16 pmRNSDirector/PDMR Dealings
1st Aug 202411:40 amRNSResult of Annual General Meeting
22nd Jul 20247:00 amRNSFollow-On Investment into Step Investments Limited
15th Jul 20247:00 amRNSAnnual Report & Notice of Annual General Meeting
27th Jun 20247:00 amRNSFinal Results for the year ended 31 March 2024
20th Jun 202411:50 amRNSInterim Dividend and Dividend Declaration
3rd Jun 20247:00 amRNSNotice of Results
17th May 202411:45 amEQSHardman & Co Q&A on Duke Capital (DUKE) | Generating investor returns by uniquely meeting customer needs
3rd May 20247:00 amRNSFollow-On Investment into Existing Capital Partner
29th Apr 20242:45 pmEQSHardman & Co Research Initiation of Coverage on Duke Capital (DUKE): Meeting customer needs, giving investors returns
3rd Apr 20247:00 amRNSFollow-On Investment into Existing Capital Partner
2nd Apr 20247:00 amRNSNew Capital Partner - Integrum Care
28th Mar 20247:00 amRNSTrading and Operational Update
21st Mar 20247:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20247:00 amRNSSuccessful Exit of Investment in Fabrikat

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.